soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 Canadian Perspectives 2025 Whiteboard on

March 13, 2026: FDA Sends Warning Letter to Novo Nordisk The FDA has sent a warning letter to the maker of Ozempic and Wegovy over a potential failure to report side effects connected to these drugs

Under Bra - 195 - 225 Say farewell to bra bulges with this treatment

Hemoglobin A1c levels typically rise within weeks to months after discontinuing GLP-1 therapy, returning toward pre-treatment values

They affect approximately 1 in 10 people in the UK at some point in their lives, with men being more commonly affected than women

The decision about which weight loss option is appropriate should always be made in partnership with your doctor, who will consider several important factors, including: Your overall health Medical history Current medications The amount of weight youre aiming to lose Your tolerance for certain treatments Always talk with your doctor when exploring effective weight loss options

In a Lira-related study, healthy male C57BL/6 rats were evenly divided into three groups, namely NC group, model control group (OC group), and Lira group